InnoCare Pharma Ltd.'s market cap is currently HK$26.23B. The company's EPS TTM is HK$-0.021862535; its P/E ratio is ―; InnoCare Pharma Ltd. is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
